Abstract 10589: Examination of the Food and Drug Administration Black Box Warning for Statins and Cognitive Dysfunction

Authors
Publication date
1 January 2013
Publisher
Doi

    Abstract

    Background: In 2012, the U.S. Food and Drug Administration (FDA) mandated black box warnings for all statin drugs for possible adverse effects on cognitive performance including memory loss, amnesi..

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Sustaining member

      University of Miami: Scholarship Miami

      redirect
      oaioai:alma.01UOML_INST:114071874...
      Last time updated on 16/01/2024